1 |
SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al. Periodontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288.
|
2 |
HELAL O, GÖSTEMEYER G, KROIS J, et al. Predictors for tooth loss in periodontitis patients: systematic review and meta-analysis[J]. J Clin Periodontol, 2019, 46(7): 699-712.
|
3 |
SLOTS J. Focal infection of periodontal origin[J]. Periodontol 2000, 2019, 79(1): 233-235.
|
4 |
WANG R P H, HO Y S, LEUNG W K, et al. Systemic inflammation linking chronic periodontitis to cognitive decline[J]. Brain Behav Immun, 2019, 81: 63-73.
|
5 |
JIA L, HAN N N, DU J, et al. Pathogenesis of important virulence factors of Porphyromonas gingivalis via toll-like receptors[J]. Front Cell Infect Microbiol, 2019, 9: 262.
|
6 |
ONO S, NAKAYAMA M, TACHIBANA M, et al. Construction and characterization of a PGN0297 mutant of Porphyromonas gingivalis: evidence of the contribution of PGN0297 to gingipain activity[J]. Acta Med Okayama, 2019, 73(4): 315-323.
|
7 |
SAKANAKA A, TAKEUCHI H, KUBONIWA M, et al. Dual lifestyle of Porphyromonas gingivalis in biofilm and gingival cells[J]. Microb Pathog, 2016, 94: 42-47.
|
8 |
HIROKI T, NAOKO S, SHUNSUKE Y, et al. Porphyromonas gingivalis induces penetration of lipopolysaccharide and peptidoglycan through the gingival epithelium via degradation of junctional adhesion molecule 1[J]. PLoS Pathog, 2019, 15(11): e1008124.
|
9 |
XU W Z, ZHOU W, WANG H Z, et al. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis[J]. Adv Protein Chem Struct Biol, 2020, 120: 45-84.
|
10 |
WADHAWAN A, REYNOLDS M A, MAKKAR H, et al. Periodontal pathogens and neuropsychiatric health[J]. Curr Top Med Chem, 2020, 20(15): 1353-1397.
|
11 |
DIETERLE M P, HUSARI A, STEINBERG T, et al. Role of mechanotransduction in periodontal homeostasis and disease[J]. J Dent Res, 2021, 100(11): 1210-1219.
|
12 |
OLSEN I. Porphyromonas gingivalis-induced neuroinflammation in Alzheimer's disease[J]. Front Neurosci, 2021, 15: 691016.
|
13 |
LIU Y C, WU Z, NAKANISHI Y, et al. Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice[J]. Sci Rep, 2017, 7(1): 11759.
|
14 |
NONAKA S, NAKANISHI H. Secreted gingipains from Porphyromonas gingivalis induce microglia migration through endosomal signaling by protease-activated receptor 2[J]. Neurochem Int, 2020, 140: 104840.
|
15 |
PATHIRANA R D, O'BRIEN-SIMPSON N M, VEITH P D, et al. Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis[J]. Microbiol Read Engl, 2006, 152(Pt 8): 2381-2394.
|
16 |
DOMINY S S, LYNCH C, ERMINI F, et al. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors[J]. Sci Adv, 2019, 5(1): eaau3333.
|
17 |
TIWARI S, ATLURI V, KAUSHIK A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics[J]. Int J Nanomed, 2019, 14: 5541-5554.
|
18 |
CALSOLARO V, EDISON P. Neuroinflammation in Alzheimer's disease: current evidence and future directions[J]. Alzheimer's Dement, 2016, 12(6): 719-732.
|
19 |
KUMAR D K V, CHOI S H, WASHICOSKY K J, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease[J]. Sci Transl Med, 2016, 8(340): 340ra72.
|
20 |
MALDONADO A, LAUGISCH O, BÜRGIN W, et al. Clinical periodontal variables in patients with and without dementia: a systematic review and meta-analysis[J]. Clin Oral Investig, 2018, 22(7): 2463-2474.
|
21 |
CHEN C K, WU Y T, CHANG Y C. Association between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study[J]. Alzheimer's Res Ther, 2017, 9(1): 56.
|
22 |
CHOI S, KIM K, CHANG J, et al. Association of chronic periodontitis on Alzheimer's disease or vascular dementia[J]. J Am Geriatr Soc, 2019, 67(6): 1234-1239.
|
23 |
DIOGUARDI M, CRINCOLI V, LAINO L, et al. The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer's disease: a systematic review[J]. J Clin Med, 2020, 9(2): 495.
|
24 |
SCHENKEIN H A, PAPAPANOU P N, GENCO R, et al. Mechanisms underlying the association between periodontitis and atherosclerotic disease[J]. Periodontol 2000, 2020, 83(1): 90-106.
|
25 |
CHHIBBER-GOEL J, SINGHAL V, BHOWMIK D, et al. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients[J]. NPJ Biofilms Microbiomes, 2016, 2: 7.
|
26 |
ANGELICA V, ELISA P, MARCELLO R, et al. The potential role of gut microbiota in Alzheimer's disease: from diagnosis to treatment[J]. Nutrients, 2022, 14(3): 668.
|
27 |
HADITSCH U, ROTH T, RODRIGUEZ L, et al. Alzheimer's disease-like neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains[J]. J Alzheimer's Dis, 2020, 75(4): 1361-1376.
|
28 |
HANSEN D V, HANSON J E, SHENG M. Microglia in Alzheimer's disease[J]. J Cell Biol, 2018, 217(2): 459-472.
|
29 |
CARTER S F, HERHOLZ K, ROSA-NETO P, et al. Astrocyte biomarkers in Alzheimer's disease[J]. Trends Mol Med, 2019, 25(2): 77-95.
|
30 |
NICHOLS M R, ST-PIERRE M K, WENDELN A C, et al. Inflammatory mechanisms in neurodegeneration[J]. J Neurochem, 2019, 149(5): 562-581.
|
31 |
KAUR D, SHARMA V, DESHMUKH R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease[J]. Inflammopharmacology, 2019, 27(4): 663-677.
|
32 |
LEYNS C E G, HOLTZMAN D M. Glial contributions to neurodegeneration in tauopathies[J]. Mol Neurodegener, 2017, 12(1): 50.
|
33 |
WU Y W, DISSING-OLESEN L, MACVICAR B A, et al. Microglia: dynamic mediators of synapse development and plasticity[J]. Trends Immunol, 2015, 36(10): 605-613.
|
34 |
PHATNANI H, MANIATIS T. Astrocytes in neurodegenerative disease[J]. Cold Spring Harb Perspect Biol, 2015, 7(6): 1-18.
|
35 |
DECOURT B, LAHIRI D K, SABBAGH M N. Targeting tumor necrosis factor alpha for Alzheimer's disease[J]. Curr Alzheimer Res, 2017, 14(4): 412-425.
|
36 |
MENDIOLA A S, CARDONA A E. The IL-1β phenomena in neuroinflammatory diseases[J]. J Neural Transm, 2018, 125(5): 781-795.
|